Additional order from Bard

Bactiguard has received a major, one off order from C.R. Bard (Bard) intended to
increase their safety stock of Bactiguard-coated Foleys for infection control.
The order will generate additional sales for Bactiguard of approximately 28 MSEK
in the third quarter and make a positive contribution to cash flow.
The additional order will lead to higher total sales to Bard for 2015 compared
to last year. Excluding this order, the underlying volume of coating concentrate
delivered to Bard in 2015 is not expected to be affected.

“Sales of Bard’s Foleys with Bactiguard’s infection control coating have been
stable over a long period of time. It is therefore encouranging that Bard has to
increase the safety stock to meet its production targets, which has a positive
impact on our revenues and makes a significant contribution to cash flow,” says
Christian Kinch, CEO.

This is information that Bactiguard Holding AB (publ) is required to publish in
compliance with the Swedish Securities Market Act and/or the Financial
Instruments Trading Act. The information was submitted for publication on 11
August 2015, at 08.30
For further information, please contact:
Cecilia Edström,  Director of Sales, Marketing &
Communications, cecilia.edstrom@bactiguard.se, mobile: 46 722 262 328
About Bactiguard
Bactiguard is a Swedish medtech company with a mission of preventing healthcare
associated infections, reducing the use of antibiotics and saving lives by
developing and supplying infection prevention solutions for the healthcare
industry. The company’s patented coating prevents healthcare associated
infections by reducing bacterial adhesion and growth on medical devices.
Bactiguard®-coated urinary catheters are market leading in the US and Japan, and
in recent years the company has developed its own product portfolio of catheters
for the urinary and respiratory tract and the blood stream. Bactiguard is
currently in a strong expansion phase, focused on new markets in the Europe,
Middle East, Asia, Latin America and Southern Africa. The company has market
presence in some 50 countries and has about 60 employees. Its headquarters is
located in Stockholm and production facilities in Sweden and Malaysia.
Bactiguard is listed on Nasdaq Stockholm. Read more about Bactiguard at
www.bactiguard.com